IRIS
POMPILIO, ARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.648
EU - Europa 2.841
AS - Asia 1.405
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 7
AF - Africa 3
OC - Oceania 3
Totale 7.915
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.627
IT - Italia 591
CN - Cina 543
IE - Irlanda 524
SG - Singapore 397
UA - Ucraina 384
SE - Svezia 381
GB - Regno Unito 371
TR - Turchia 278
FR - Francia 183
DE - Germania 145
IN - India 97
RU - Federazione Russa 88
FI - Finlandia 78
VN - Vietnam 42
BE - Belgio 17
ES - Italia 15
AT - Austria 13
CH - Svizzera 13
CZ - Repubblica Ceca 12
JP - Giappone 12
MX - Messico 11
HK - Hong Kong 8
CA - Canada 7
EU - Europa 7
KR - Corea 7
IR - Iran 6
BR - Brasile 5
NL - Olanda 5
PL - Polonia 4
TH - Thailandia 4
GR - Grecia 3
RS - Serbia 3
BD - Bangladesh 2
BG - Bulgaria 2
IQ - Iraq 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AU - Australia 1
BZ - Belize 1
DK - Danimarca 1
IL - Israele 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
SC - Seychelles 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 7.915
Salva come PNG Salva come JPEG
Città #
Chandler 835
Jacksonville 550
Dublin 519
Singapore 334
Dearborn 281
Princeton 252
Southend 208
Ashburn 182
Chieti 162
Nanjing 148
Izmir 142
Beijing 120
Wilmington 95
Santa Clara 83
Ann Arbor 79
Cambridge 74
Altamura 68
Nanchang 48
Boardman 46
Dong Ket 42
Los Angeles 41
Washington 38
Kunming 26
Hebei 25
Rome 25
New York 23
Shenyang 23
Jiaxing 22
Munich 22
Norwalk 22
Woodbridge 21
Tianjin 20
Brussels 16
Teramo 15
Pune 13
Vienna 13
Falls Church 12
Milan 12
Moscow 12
Changsha 10
Civitanova Marche 10
Houston 10
Kocaeli 10
Palermo 10
Pescara 10
Varallo 9
Chicago 8
Hefei 8
Hong Kong 8
Seattle 8
Grevenbroich 7
Guangzhou 7
Jinan 7
Orange 7
Vittuone 7
Zhengzhou 7
Brno 6
Ciudad de Villa de Álvarez 6
Geneva 6
Helsinki 6
Lanzhou 6
Melfi 6
Napoli 6
Putignano 6
Ascoli Piceno 5
Augusta 5
Bellaterra 5
Castel Gandolfo 5
Ferrara 5
L'aquila 5
Monfalcone 5
Paris 5
San Mateo 5
Shanghai 5
Udine 5
Zurich 5
Bologna 4
Chennevières-sur-marne 4
Hangzhou 4
Lappeenranta 4
New Delhi 4
Sabadell 4
São Paulo 4
Tappahannock 4
Tehran 4
Amsterdam 3
Bari 3
Castellana Grotte 3
Catania 3
Chengdu 3
Delhi 3
Edinburgh 3
Florence 3
Lanciano 3
Molise 3
Montreal 3
Ningbo 3
Orsogna 3
Perugia 3
Phoenix 3
Totale 5.001
Salva come PNG Salva come JPEG
Nome #
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp. pasteurianus 185
Attività battericida ed anti-biofilm di peptidi antimicrobici verso patogeni multi-resistenti isolati da pazienti con fibrosi cistica. 128
Fatal sepsis by Klebsiella pneumoniae in a patient with systemic lupus erythematosus: the importance of postmortem microbiological examination for the ex post diagnosis of infection. 120
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 108
Colonic adenoma-associated Escherichia coli express specific phenotypes 105
Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm 101
Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis 99
Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA). 98
Meticillin-heteroresistant Staphylococcus pasteuri from an apheresis platelet product 94
Antibiotic resistance and biofilm in Stenotrophomonas maltophilia isolates from cystic fibrosis and non-cystic fibrosis patients 91
Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosis. 89
Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. 88
Misidentification of ampicillin-sulbactam heteroresistance in Acinetobacter baumannii strains from ICU patients 86
In vitro microbiology studies on a new peritoneal dialysis connector 86
Risk of misidentification of Enterobacter aerogenes inducible cephalosporinases. 85
Adhesion and biofilm formation by Staphylococcus aureus clinical isolates under conditions relevant to the host: Relationship with macrolide resistance and clonal lineages 85
Analisi proteomica del biofilm formato da un ceppo di Stenotrophomonas maltophilia isolato da fibrosi cistica. 84
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria 83
An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia. 82
Effetto di concentrazioni sub-inibenti di moxifloxacina su Stenotrophomonas maltophilia isolati da fibrosi cistica 81
Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient 81
Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia strains. 80
Cell surface hydrophobicity, motility, and biofilm formation of Stenotrophomonas maltophilia clinical isolates. 79
Serum and mucosal cytokine profiles in patients with active Helicobacter pylori and ischemic heart disease: is their a relationship ? 79
Determination of ciprofloxacin and levofloxacin in human sputum collected from cystic fibrosis patients using microextraction by packed sorbent-high performance liquid chromatography photodiode array detector 79
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 79
Evolution of Stenotrophomonas maltophilia in Cystic Fibrosis Lung over Chronic Infection: A Genomic and Phenotypic Population Study 79
An overview on streptococcus bovis/streptococcus equinus complex isolates: Identification to the species/subspecies level and antibiotic resistance 79
Myroides odoratimimus Forms Structurally Complex and Inherently Antibiotic-Resistant Biofilm in a Wound-Like in vitro Model. 78
Effect of levofloxacin on Stenotrophomonas maltophilia biofilm and its relationship with SmeDEF multidrug efflux pump expression under conditions relevant to the cystic fibrosis lung 78
A novel biotechnology product for the degradation of biofilm-associated polysaccharides produced by Streptococcus mutans 77
Infection of recurrent calcaneal ulcer caused by a biofilm-producer Myroides odoratimimus strain. 77
Isolation of colistin-resistant Hafnia alvei. 77
Peptide dendrimers as “lead compounds” for the treatment of chronic lung infections by Pseudomonas aeruginosa in cystic fibrosis patients: In vitro and in vivo studies 77
In vitro activity of levofloxacin against planktonic and biofilm Stenotrophomonas maltophilia lifestyles under conditions relevant to pulmonary infection in cystic fibrosis, and relationship with SmeDEF multidrug efflux pump expression 77
Evaluation of antibacterial and antibiofilm mechanisms by usnic acid against methicillin-resistant Staphylococcus aureus 76
Alterazione dei livelli tessutali di ioni metallici in un modello murino di infezione polmonare da Stenotrophomonas maltophilia. 75
Eparina sodica stimola la formazione di biofilm da parte di Providencia stuartii. 74
Subinhibitory concentrations ofmoxifloxacin decrease adhesion and biofilm formation of Stenotrophomonasmaltophilia from cystic fibrosis. 74
Anaerobiosi ed ambiente acido influenzano l’attività in vitro di colistina nei confronti del biofilm formato da ceppi di Pseudomonas aeruginosa isolati da pazienti affetti da fibrosi cistica. 74
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. 73
Antibacterial and anti-biofilm effects of cathelicidin peptides against pathogens isolated from cystic fibrosis patients. 73
Multidrug-resistant Geotrichum capitatum from a haematology ward. 72
D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection 72
Microbial cooperation in cystic fibrosis: Stenotrophomonas maltophilia significantly modulates Pseudomonas aeruginosa virulence. 72
Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence. 71
In vitro bactericidal and antibiofilm activity of six antimicrobial peptides against multidrug-resistant pathogens from patients with cystic fibrosis. 71
Disomeostasi cationica in un modello murino di infezione polmonare da Stenotrophomonas maltophilia 71
Haemophilus influenzae in children with cystic fibrosis: antimicrobial susceptibility, molecular epidemiology, distribution of adhesins and biofilm formation. 70
Stenotrophomonas maltophilia mutant lacking flagella remains virulent in DBA/2N mice but is less efficient in stimulating TNF-α expression 70
A new challenge in cystic fibrosis antimicrobial therapy: activity of electrochemically synthesized silver nanoparticles against planktonic and biofilm cells of bacterial pathogens 70
Exposure to extremely low-frequency magnetic field affects biofilm formation by cystic fibrosis pathogens 69
Determinazione di Ciprofloxacina e Levofloxacina in espettorato da pazienti affetti da fibrosis cistica mediante MEPS-HPLC-PDA 69
Tuberculosis-like pneumonias by the aerobic actinomycetes Rhodococcus, Tsukamurella and Gordonia. 69
In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions 69
Factors associated with adherence to and biofilm formation on polystyrene byStenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. 68
Helicobacter pylori Outer Membrane Vesicles (OMVs) as DNA shuttles and structural components of biofilm EPS 68
New insights in Staphylococcus pseudintermedius pathogenicity: antibiotic-resistant biofilm formed by a human wound-associated strain. 68
New insights in Staphylococcus pseudintermedius pathogenicity: Antibiotic-resistant biofilm formation by a human wound-associated strain 67
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 67
Ruolo epidemiologico del biofilm in isolati di Stenotrophomonas maltophilia da pazienti con fibrosi cistica e da pazienti ricoverati in unità di terapia intensiva 66
V240H replacement, by site-directed mutagenesis, increases resistance toward carbapenems in TEM-149 ESBL producing E. coli. 65
Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia. A tale of a colonized bladder device in a patient with myelofibrosis. 64
Normal breathing releases SARS-CoV-2 into the air 64
Staphylococcus pasteuri bacteraemia in a patient with leukaemia. 63
Attvità antibatterica ed anti-biofilm del peptide P19(9/B) verso isolati multi-resistenti isolati da pazienti affetti da fibrosi cistica 63
Studio microbiologico in vitro su di un nuovo connettore per dialisi peritoneale 63
An antimicrobial bicyclic peptide from chemical space against multidrug resistant Gram-negative bacteria 63
Comparative evaluation of the Vitek-2 Compact and Phoenix systems for rapid identification and antibiotic susceptibility testing directly from blood cultures of Gram-negative and Gram-positive isolates. 62
Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients 62
A cystic fibrosis child with lung function decline 62
Toward optimization of antimicrobial peptides for the treatment of multidrug resistant infections in cystic fibrosis. 62
Hafnia alvei from the farm to the delivery room 62
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. 61
Characterization of biofilm formation by Myroides odoratimimus isolated from post-traumatic calcaneal recurrent ulcer in diabetic patient 61
Bacterial contamination of platelets and septic transfusions: review of the literature and discussion on recent patents about biofilm treatment. 60
Patogenesi in fibrosi cistica: clearance di Stenotrophomonas maltophilia ed infiammazione in un modello murino di infezione polmonare. 60
Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients. 59
Identification, antimicrobial resistance and molecular characterization of the human emerging pathogen Streptococcus gallolyticus subsp pasteurianus 59
Formazione di biofilm, diversità genetica e virulenza in Stenotrophomonas maltophilia isolati da pazienti con fibrosi cistica. 58
Identification of CTX-M-15 and CTX-M-27 in Antibiotic-Resistant Gram-Negative Bacteria Isolated from Three Rivers Running in Central Italy 58
ONE-STEP DEPOSITION METHOD FOR THE SYNTHESIS OF A NANOCOMPOSITE MEMBRANE BASED ON REDUCED GRAPHENE OXIDE/ZEOLITE-A FOR ADSORPTION OF METAL IONS WITH ENHANCED ANTIBACTERIAL PROPERTIES 58
Olive Pâté by Multi-Phase Decanter as Potential Source of Bioactive Compounds of Both Nutraceutical and Anticancer Effects 58
Corynebacterium glucuronolyticum causing genitourinary tract infection: Case report and review of the literature 57
Clonal diversity, biofilm formation, and antimicrobial resistance among Stenotrophomonas maltophilia strains from cystic fibrosis and non-cystic fibrosis patients 57
Stenotrophomonas maltophilia phenotypic and genotypic diversity during a 10-year infection in the lungs of a cystic fibrosis patient 56
Modulation of biofilm formation by Stenotrophomonas maltophilia during chronic lung infection in cystic fibrosis patients: a longitudinal population study 55
The anti-microbial peptide (Lin-SB056-1)2-K reduces pro-inflammatory cytokine release through interaction with Pseudomonas aeruginosa lipopolysaccharide 55
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 55
Molecular genotyping, adhesion and biofilm formation in methicillin-resistant Staphylococcus aureus clinical strains. 54
Attvità antibatterica ed anti-biofilm di BMAP-27 e BMAP-28 verso ceppi multi-resistenti isolati da pazienti affetti da fibrosi cistica 54
An ultrathin film membrane based on a nano-channeled reduced graphene oxide with enhanced antibacterial properties 54
Efficacy of phages and antibiotic-phage combinations against biofilm by Pseudomonas aeruginosa from cystic fibrosis patients 54
“Indirect pathogenicity” in cystic fibrosis during pulmonary exacerbations: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in a Galleria mellonella model. 54
In vitro bactericidal and anti-biofilm activity of bovine myeloid antimicrobial peptides against multidrug-resistant bacteria from patients with cystic fibrosis. 53
Biofilm formation and antibiotic resistance in Stenotrophomonas maltophilia: a prospective multicentre study 53
Ambient air pollution and respiratory bacterial infections, a troubling association: epidemiology, underlying mechanisms, and future challenges 52
Ruolo della componente flagellare nella patogenicità di Stenotrophomonas maltophilia in fibrosi cistica. 51
null 51
Interazione in vitro tra Stenotrophomonas maltophilia e cellule epiteliali bronchiali IB3-1: implicazioni in fibrosi cistica. 50
Totale 7.254
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.064 0 0 0 0 182 170 202 118 52 136 184 20
2020/2021751 105 18 150 25 56 135 13 18 40 98 24 69
2021/2022828 27 39 31 121 60 22 35 62 85 20 94 232
2022/20232.073 179 270 156 248 184 384 105 152 254 25 83 33
2023/2024918 61 50 79 33 80 250 194 47 12 25 8 79
2024/2025843 119 360 245 73 46 0 0 0 0 0 0 0
Totale 8.559